Covid-19: Two shot vaccine by Zydus gets SEC nod https://ift.tt/yRgo4rn

Soon a two-shot Covid-19 vaccine of Zydus Cadila could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee (SEC) under the health ministry, paving the way for a nod by the drug regulator soon, sources told TOI.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/ZY4NRP1